Anti-MU5AC Reference Antibody (ensituximab)
分享
收藏
产品详情
FAQ
产品文档
已发表文献
推荐应用
产品介绍
Ensituximab (NEO-102; NPC-1C) 是一种靶向 MUC5AC 变体的嵌合单克隆 IgG1 抗体。Ensituximab 显示出对结直肠癌和胰腺癌的特异性。
产品性质
产品特色
For Powder, reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
应用案例

本产品仅用作科学研究!


Anti-MU5AC Reference Antibody (ensituximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

The purity of Anti-MU5AC Reference Antibody (ensituximab) is more than 95%, determined by SEC-HPLC.

存储条件
-80°C for 2 years under sterile conditions;-20°C for 1 year under sterile conditions;Avoid repeated freeze-thaw cycles.
COA
已发表文献
联系我们
购物车
客服
转染试用